The purpose of the Kaganov Research Initiative in Pulmonary Medicine and Engineering, supported by a generous gift from Dr. Alan and Mrs. Carol Kaganov, is to build robust collaborations between engineers and biomedical scientists or clinicians to conduct basic, translational or clinical research that focuses directly on or has relevance to lung function and diseases, especially pulmonary fibrosis. To achieve this purpose, the Initiative will fund multiple research proposals.
The Kaganov Research Initiative in Pulmonary Medicine and Engineering focuseson research onlung function or diseases of the lung, especially pulmonary fibrosis, with the following priorities:
- improve our understanding of disease mechanisms,
- enhance diagnosis,
- create more effective treatments
- find pathways to cure idiopathic pulmonary fibrosis and other lung diseases.
Grant proposals should describe multidisciplinary research that meaningfully engages investigators from at least the Schools of Engineering and Medicine. Research on relevant basic biomedical questions, development of enhanced understanding of disease mechanism, the development of therapies, diagnostics or devices, clinical research/trials (excluding Phase 2 or beyond), epidemiological, and/or community-based studies is within scope. The Initiative is especially interested in proposals that build new collaborations and/or teams, and proposals that might lead to extended, productive collaborations and follow-on funding.
A Kaganov Initiative grant application need not have extensive background material or preliminary data. Accordingly, reviewers will be encouraged to focus their evaluations on the conceptual framework, the level of innovation, and the potential to significantly advance our knowledge or understanding of or the treatment of lung disease, particularly idiopathic pulmonary fibrosis. Appropriate justification for the proposed work can be provided through literature citations, data from other sources or from investigator-generated data. All applications should discuss a path to subsequent financial support through grant funding, new company formation, licensing, not-for-profit partnering, or other channels.
Application submission deadline: October 30, 2019